Combo Products Typically Would Require Only One User Fee Payment – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is proposing to levy two user fees from a combination product sponsor if separate marketing applications are filed, though one of the fees would be waived under certain circumstances